Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 6, 1998, Pages 715-720

  Pérez Fuentes, Ricardo ^a   Sánchez Guillén, Maria Del Carmen ^b   González Alvarez, Carlos ^b   Monteón, Victor M ^c   Reyes, Pedro A ^c   Rosales Encina, José L ^d  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CHAGAS DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION RISK; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; SERODIAGNOSIS; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI;

EID: 2642706701     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.715     Document Type: Article

References (46)

1. Moncayo A, 1992. Chagas' disease. Epidemiology and prospects for interruption of transmission in the Americas. World Health Stat Q 145 :276-279.
2. Schofield CJ, 1985. Control of Chagas' disease vectors. Br Med J 41: 187-194.
3. Moncayo-Medina A, 1987. Chagas' disease. Maurice J, Pearce AM, eds. Tropical Disease Research: A Global Partnership: Eighth Programme Report. Geneva: World Health Organization. 87-98.
4. Moncayo-Medina A, 1993. Chagas' disease. Maurice J, Pearce AM, eds. Tropical Disease Research. Eleventh Programme Report. Geneva: UNDP/World Bank/WHO. ATRS S.A.
5. Velasco CO, Valdespino JL, Tapia CR, Salvatierra V, Guzman BC, Magos C, Llausas A, Gutierrez G, Sepulveda J, 1992. Seroepidemiologia de la entermedad de Chagas en Mexico. Salud Publica Mex 32: 186-196.
6. Ruegsengger-de-Gutierrez GL, Monteon VM, Marcushamer J, Reyes PA, 1993. Tripanosomiasis americana (Enfermedad de Chagas). Encuesta clinico-serologica en un municipio rural oaxaqueno. Arch Inst Cardiol Mex 63: 145-148.
7. Dusaing DG, 1993. Trypanosoma (Scizotrypatum) cruzi. Kreier JP, Baker JR, eds. Parasitic Protozoa. Second edition. Volume 1, Chapter 4. New York: Academic Press, 137-194.
8. Teixeira ARL, Teixeira G, Macedo V, Prata A, 1978. Acquired cell-mediated immunodepression in acute Chagas' disease. J Clin Invest 62: 1132-1141.
9. De Tito EH, Braun M, Lazzari JO, Segura LL, 1985. Cell-mediated reactivity against human and Trypanosoma antigens according to clinical status in Chagas' disease patients. Immunol Lett 9: 249-254.
10. Tarleton RL, Kholer BH, Latour A, Ponstan M, 1992. Susceptibility of β-2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338-340.
11. Harell-Bellan A, Joskowcz M, Fradelizi D, Eisen H, 1983. Modification of T-cell proliferation and interleukin production in mice with Trypanosoma cruzi. Proc Natl Acad Sci 80: 3466-3469.
12. Ramos C, Schadtler-Siwon I, Ortiz-Ortiz L, 1979. Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice. J Immunol 122: 1243-1247.
13. Voltarelli JD, Dinadi EA, Falcno RP, 1987. Immunosuppression in human acute Chagas' disease. Trans R Soc Trop Med Hyg 81: 169-170.
14. Gusmao RD, Rezende JM, Rassi A, Gam AA, Neva FA, 1982. Antibody levels to Trypanosoma cruzi in infected patients with and without evidence of chronic Chagas' disease. Am J Trop Med Hyg 31: 452-458.
15. Cetron MS, Basilio FP, Moraes AP, Sousa AQ, Paes JN, Khan SJ, Wener MH, Van Voorhis WC, 1993. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection. Am J Trop Med Hyg 49: 370-382.
16. Metz G, Carlier Y, Vray B, 1993. Trypanosoma cruzi nitric oxide release by IFN-γ-preactivated macrophages, limiting cell infection independently of the respiratory burst. Parasite Immunol 15: 693-699.
17. Bogdan C, Stenger S, Rollinghoff M, Slobach W, 1991. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-γ to activate murine macrophages for killing of Leishmania major amastigotes. Eur J Immunol 21: 237-333.
18. Vincendeau P, de Daloue S, 1991. Macrophage cytostatic effects on Trypanosoma musculi involves an L-arginine-dependent mechanism. J Immunol 146: 4338-4343.
19. Vincendeu P, de Daloue S, Veyret B, Darde M, Bouteille B, Lemerse J, 1992. Nitric oxide-mediated cylostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp Parasitol 75: 353-360.
20. Prada J, Kremsner PG, 1995. Enhanced production of reactive nitrogen intermediates in human and murine malaria. Parasirol Today 11: 409-410.
21. Rockett KA, Awburn MM, Rockett EJ, Cowden WB, Clark IA, 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol 16: 243-249.
22. Nhssler AK, Eling W, Kremsner PG, 1994. Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels. J Infect Dis 169: 1418-1419.
23. Ley V, Andrews NW, Robbins ES, Nussenzweig V, 1988. Amasligotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J Exp Med 168: 649-659.
24. Monteon PV, Sosa T, Reyes PA, 1989. Serological tests for American trypanosomiasis. A comparative study. Rev Latinoamer Microbiol 31: 35-38.
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR, 1982. Analysis of nitrite, nitrate, and (15N) nitrate in biological fluids. Anal Biochem 126: 131-138.
26. Araujo FG, Remington JS, 1981. Characterization of stages and strains of Trypanosoma cruzi by analysis of cell membrane components. J Immunol 127: 855-858.
27. Bongertz V, Dvorak JA, 1983. Trypanosoma cruzi: antigenic analysis of cloned stocks. Am J Trop Med Hyg 32: 716-722.
28. Bongertz V, Pontes de Carvalho LC, 1992. Production of monoclonal antibodies for the identification of a strain of Trypanosoma cruzi. Am J Trop Med Hyg 46: 435-439.
29. Morato MIF, Brener Z, Cancado ZR, Nunes RMB, Chiari E, Gazzinelli G, 1986. Cellular immune responses of chagasic patients to antigen derived from Trypanosoma cruzi strains and clones. Am J Trop Med Hyg 35: 505-511.
30. Gusmao RD, Rassi A, Rezende JM, Neva FA, 1984. Specific and non-specific lymphocyte blastogenic responses in individuals infected with Trypanosoma cruzi. Am J Trop Med Hyg 33: 827-834.
31. Colley DG, Howard JM, 1991. The fundamental nature of Chagas' disease: a view provided by immune responses and idiotypes. Jpn J Trop Med Hyg 19: 175-182.
32. Mosca W, Plaja J, Hubsch R, Cedillos R, 1985. Longitudinal study of immune response in human Chagas' disease. J Clin Microbiol 22: 438-441.
33. Clark IA, Cowden WB, Rockett KA, 1995. Nitric oxide in cerebral malaria. J Infect Dis 171: 1068-1069.
34. Clark IA, Cowden WB, Rockett KA, 1993. Nitric oxide and cerebral malaria. Lancet 341: 632-633.
35. Cot S, Ringwald P, Mulder B, Miailhes P, Yap-Yap J, Nussler AK, Eling WMC, 1994. Nitric oxide in cerebral malaria. J Infect Dis 169: 1417-1418.
36. Clark LA, Al Yaman F, Rockett KA, 1995. Enhanced production of reactive nitrogen intermediates in human and murine malaria: replay. Parasitol Today 11: 424-425.
37. Lopes ER, Chapadeiro E, Almeida HO, Rocha A, 1975. Contribucao ao estudo da anatomia patologica dos caracoes chagasicos falecidos subitamente. Rev Soc Braz Med Trop 9: 269-282.
38. Lopes ER, Chapadeiro E, Andrade ZA, Almeida HO, Rocha A, 1981. Patological anatomy of hearts from asymptomatic Chagas' disease patients dying in a violent manner. Mem Inst Oswaldo Cruz 76: 189-197.
39. Andrade ZA, 1984. The canine model of Chagas' disease. Mem Inst Oswaldo Cruz 79: 77-83.
40. Andrade ZA, Andrade SG, Sadigursky M, 1987. Enhancement of chronic Trypanosoma cruzi myocarditis of dogs treated with low doses of cyclophosphamide. Am J Pathol 127: 467-473.
41. Sun J, Tarleton R, 1993. Predominance of CD8 + T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop Med Hyg 48: 161-169.
42. Tsujino M, Hirata Y, Imai T, Kanno K, Eguchi S, Ito H, Marumo F, 1994. Induction of nitric oxide synthase gene by interleukin-1β in cultured rat cardiocytes. Circulation 90: 375-383.
43. Balligand JL, Ungureanu D, Kelly RA, Pimental D, Michel T, Smith TW, 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314-2319.
44. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuck GD, 1995. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor-α. Br J Pharmacol 114: 27-34.
45. 2+], and cell contraction in cultured chick ventricular myocytes. Circulation Res 75: 285-295.
46. Garcia SB, Paula JS, Giovannetti GS, Zucoloto S, Silva JS, Cunha FQ, 1996. Nitric oxide is involved in the intestinal denervation observed in the acute phase of experimental Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 91(suppl): 43-44.